• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY LAP-BAND AP STANDARD W/ ACCESS PORT II; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY LAP-BAND AP STANDARD W/ ACCESS PORT II; ADJUSTABLE GASTRIC BAND Back to Search Results
Model Number B-2260
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 01/31/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Taper ii.Device labeling addresses the reported event as follows: precautions: care must be taken during band adjustment to avoid puncturing the tubing that connects the access port and band, as this will cause leakage and deflation of the inflatable section.Failure to create a stable, smooth path for the access port tubing, without sharp turns or bends, can result in tubing breaks and leakage.In order to avoid incorrect placement, the port should be placed lateral to the trocar opening.A pocket must be created for the port so that it is placed far enough from the trocar path to avoid abrupt kinking of the tubing.The tubing path should point in the direction of the access port connector so that the tubing will form a straight line with a gentle arching transition into the abdomen.Adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Ulceration, gastritis, gastroesophageal reflux, heartburn, gas bloat, dysphagia, dehydration, constipation, and weight regain have been reported after gastric restriction procedures.Unplanned deflation of the band may occur due to leakage from the band, the port or the connecting tubing.Warnings: patients should be advised that the lap-band system is a long-term implant.Explant (removal)and replacement surgery may be indicated at any time.Medical management of adverse reactions may include explantation.Revision surgery for explantation and replacement may also be indicated to achieve patient satisfaction.
 
Event or Problem Description
Reported as: a patient with the lap-band system was reported to have a leak."[patient] has lacked of satiety.Injection of fluid and attempts of aspiration through [patient's] port revealed that there was no fluid in system, and injection was not returned indicating a complete disruption of [patient's] tubing which is confirmed radio graphically breaking the tubing at the metal connector with the tip of the tubing being in the pelvis.This was laparoscopically retrieved." the device was removed.
 
Additional Manufacturer Narrative
Taper ii.Device evaluation summary: the device was returned to apollo for analysis, and visual examination confirmed the connector type as taper ii.Scratches were noted on the port, and needle marks were observed on the port septum.A port leak test was performed, and no leakage was noted.A fill inspection test was performed, and no blockage was noted when di water was injected into both the port septum, and into the port tubing.The port tubing was observed to be separated approximately 2.5 inches from the taper tubing junction.Under microscopic analysis, the end of the port tubing was noted to have striated edges, consistent with a surgical end cut and device removal activities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND AP STANDARD W/ ACCESS PORT II
Common Device Name
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
APOLLO ENDOSURGERY
1120 s. captial tx hwy
bldg. 1 suite 300
austin TX 78746
MDR Report Key6785653
Report Number3006722112-2017-00278
Device Sequence Number1116163
Product Code LTI
UDI-Device Identifier10811955020220
UDI-Public10811955020220
Combination Product (Y/N)N
Initial Reporter StateAR
Initial Reporter CountryUS
PMA/510(K) Number
P000008
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2017
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Physician
Device Expiration Date10/31/2009
Device Model NumberB-2260
Device Catalogue NumberB-2260
Device Lot Number1510241
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/25/2017
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 07/14/2017
Supplement Date Received by Manufacturer08/28/2017
Initial Report FDA Received Date08/10/2017
Supplement Report FDA Received Date09/25/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age36 YR
Patient Weight73
-
-